Cardiovascular Consequences of Marijuana Use
Abstract
This review describes what is known about effects of marijuana and cannabinoids in relation to human physiological and disease outcomes. The acute physiological effects of marijuana include a substantial dose‐dependent increase in heart rate, generally associated with a mild increase in blood pressure. Orthostatic hypotension may occur acutely as a result of decreased vascular resistance. Smoking marijuana decreases exercise test duration in maximal exercise tests, increases the heart rate at submaximal levels of exercise. Tolerance develops to the acute effects of marijuana smoking and Δ9‐tetrahydrocannibol (THC) over several days to a few weeks. The cardiovascular responses that occur in response to THC are mediated by the autonomic nervous system, with recent findings also demonstrating that the human cannabinoid receptor system plays a role in regulating the cardiovascular response. Although several mechanisms exist by which marijuana use might contribute to the development of chronic cardiovascular conditions or acutely trigger cardiovascular events, there are few data regarding marijuana/THC use and cardiovascular disease outcomes. A large cohort study showed no association of marijuana use with cardiovascular disease hospitalization or mortality. However, acute effects of marijuana use include a decrease of the time until the onset of chest pain in patients with angina pectoris; one study has shown that marijuana may trigger the onset of myocardial infarction. Patients who have coronary heart disease or are at high risk for the development of CHD should be cautioned about the potential hazards of marijuana use as a precipitant for clinical events. Research directions might include more studies of cardiovascular disease outcomes and relationships of marijuana with cardiovascular risk factors, studies of metabolic and physiologic effects of chronic marijuana use that may affect cardiovascular disease risk, increased understanding of the role of the cannabinoid receptor system in cardiovascular regulation, and studies to determine if there is a therapeutic role for cannabinoids in blood pressure control or for neuroprotection after stroke.
Citing Literature
Number of times cited according to CrossRef: 105
- Salahaden R. Sultan, Saoirse E. O'Sullivan, Timothy J. England, The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial, British Journal of Clinical Pharmacology, 10.1111/bcp.14225, 86, 6, (1125-1138), (2020).
- Caroline J. Porr, Patricia Rios, Harpreet S. Bajaj, Aoife M. Egan, Celine Huot, Ryan Batten, Lisa Bishop, Devonne Ryan, Erin Davis, Nazia Darvesh, Arifur Rahman, Shabnam Asghari, Lily Acheampong, Andrea C. Tricco, The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: a rapid review, Systematic Reviews, 10.1186/s13643-020-01411-9, 9, 1, (2020).
- Marieka V. DeVuono, Linda A. Parker, Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms, Cannabis and Cannabinoid Research, 10.1089/can.2019.0059, (2020).
- Zara Latif, Nadish Garg, The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use, Journal of Clinical Medicine, 10.3390/jcm9061925, 9, 6, (1925), (2020).
- Julian Jakob, Odile Stalder, Lamprini Syrogiannouli, Mark J. Pletcher, Eric Vittinghoff, Hongyan Ning, Kali Tal, Jamal S. Rana, Stephen Sidney, Donald M. Lloyd‐Jones, Reto Auer, Association between marijuana use and electrocardiographic abnormalities by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study, Addiction, 10.1111/add.15188, 0, 0, (2020).
- Jag H. Khalsa, Ruben Baler, Medical Consequences of Cannabis Use, Cannabis Use Disorders, 10.1007/978-3-319-90365-1, (157-167), (2019).
- Olaf H. Drummer, Dimitri Gerostamoulos, Noel W. Woodford, Cannabis as a Cause of Death: A Review, Forensic Science International, 10.1016/j.forsciint.2019.03.007, (2019).
- Moyukh Ghosh, Sahar Naderi, Cannabis and Cardiovascular Disease, Current Atherosclerosis Reports, 10.1007/s11883-019-0783-9, 21, 6, (2019).
- Jonathon K. Lisano, Jeremy D. Smith, Alissa B. Mathias, Matthew Christensen, Peter Smoak, Kristina T. Phillips, Colin J. Quinn, Laura K. Stewart, Performance and Health-Related Characteristics of Physically Active Males Using Marijuana, Journal of Strength and Conditioning Research, 10.1519/JSC.0000000000002238, 33, 6, (1658-1668), (2019).
- Meki Bilici, Mehmet Ture, Hasan Balik, Myocardial Infarction in Children, Myocardial Infarction, 10.5772/intechopen.69907, (2019).
- Miriam Schneider, Chris Maria Friemel, Rupert von Keller, Kristina Adorjan, Udo Bonnet, Alkomiet Hasan, Derik Hermann, Joseph Kambeitz, Dagmar Koethe, Ludwig Kraus, F. Markus Leweke, Beat Lutz, Liane Paul, Oliver Pogarell, Ulrich Preuss, Michael Schäfer, Sophia Schmieder, Roland Simon, Martin Storr, Eva Hoch, Cannabiskonsum zum Freizeitgebrauch, Cannabis: Potenzial und Risiko, 10.1007/978-3-662-57291-7, (65-264), (2019).
- Madeline H. Meier, Dustin Pardini, Jordan Beardslee, Karen A. Matthews, Associations Between Cannabis Use and Cardiometabolic Risk Factors, Psychosomatic Medicine, 10.1097/PSY.0000000000000665, 81, 3, (281-288), (2019).
- Theresa Winhusen, Jeff Theobald, David C. Kaelber, Daniel Lewis, The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990.2019.1676433, (1-8), (2019).
- Carsten Buhmann, Tina Mainka, Georg Ebersbach, Florin Gandor, Evidence for the use of cannabinoids in Parkinson’s disease, Journal of Neural Transmission, 10.1007/s00702-019-02018-8, (2019).
- Joshua Briscoe, Arif H. Kamal, David J. Casarett, Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis, Journal of Palliative Medicine, 10.1089/jpm.2018.0641, (2019).
- Samantha Brumbach, Shawn S. Goodman, Rachael R. Baiduc, Behavioral Hearing Thresholds and Distortion Product Otoacoustic Emissions in Cannabis Smokers, Journal of Speech, Language, and Hearing Research, 10.1044/2019_JSLHR-H-18-0361, (1-16), (2019).
- Alison C Burggren, Anaheed Shirazi, Nathaniel Ginder, Edythe D. London, Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990.2019.1634086, (1-17), (2019).
- Rahi Abouk, Scott Adams, Examining the relationship between medical cannabis laws and cardiovascular deaths in the US, International Journal of Drug Policy, 10.1016/j.drugpo.2017.11.022, 53, (1-7), (2018).
- Alyssa M. Parian, Gerard E. Mullin, Jost Langhorst, Amy C. Brown, Inflammatory Bowel Disease, Integrative Medicine, 10.1016/B978-0-323-35868-2.00050-5, (501-516.e8), (2018).
- Ersilia M. DeFilippis, Avinainder Singh, Sanjay Divakaran, Ankur Gupta, Bradley L. Collins, David Biery, Arman Qamar, Amber Fatima, Mattheus Ramsis, Daniel Pipilas, Roxanna Rajabi, Monica Eng, Jon Hainer, Josh Klein, James L. Januzzi, Khurram Nasir, Marcelo F. Di Carli, Deepak L. Bhatt, Ron Blankstein, Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction, Journal of the American College of Cardiology, 10.1016/j.jacc.2018.02.047, 71, 22, (2540-2551), (2018).
- Liat Korn, Denise L. Haynie, Jeremy W. Luk, Bruce G. Simons-Morton, Prospective associations between cannabis use and negative and positive health and social measures among emerging adults, International Journal of Drug Policy, 10.1016/j.drugpo.2018.05.003, 58, (55-63), (2018).
- Oscar J. León, Leonar G. Aguiar, Leonardo A. Quevedo, Ana B. Jara, Efectos cardiovasculares debido al consumo de cannabinoides, Revista Colombiana de Cardiología, 10.1016/j.rccar.2017.11.030, 25, 3, (230-235), (2018).
- Naghum Alfulaij, Franziska Meiners, Justin Michalek, Andrea L. Small‐Howard, Helen C. Turner, Alexander J. Stokes, Cannabinoids, the Heart of the Matter, Journal of the American Heart Association, 10.1161/JAHA.118.009099, 7, 14, (2018).
- Federico Corvi, Giuseppe Querques, Rosangela Lattanzio, Chiara Preziosa, Maurizio Battaglia Parodi, Francesco Bandello, Central Retinal Vein Occlusion in a Young Patient following Cannabis Smoke Inhalation, European Journal of Ophthalmology, 10.5301/ejo.5000400, 24, 3, (437-440), (2018).
- Thea Bjune, Bjarke Risgaard, Line Kruckow, Charlotte Glinge, Ole Ingemann-Hansen, Peter Mygind Leth, Kristian Linnet, Jytte Banner, Bo Gregers Winkel, Jacob Tfelt-Hansen, Post-mortem toxicology in young sudden cardiac death victims: a nationwide cohort study, EP Europace, 10.1093/europace/euw435, 20, 4, (614-621), (2017).
- Amitoj Singh, Sajeev Saluja, Akshat Kumar, Sahil Agrawal, Munveer Thind, Sudip Nanda, Jamshid Shirani, Cardiovascular Complications of Marijuana and Related Substances: A Review, Cardiology and Therapy, 10.1007/s40119-017-0102-x, 7, 1, (45-59), (2017).
- Barbara A Yankey, Richard Rothenberg, Sheryl Strasser, Kim Ramsey-White, Ike S Okosun, Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file, European Journal of Preventive Cardiology, 10.1177/2047487317723212, 24, 17, (1833-1840), (2017).
- Khalid A. Jadoon, Garry D. Tan, Saoirse E. O’Sullivan, A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study, JCI Insight, 10.1172/jci.insight.93760, 2, 12, (2017).
- Jared P. Reis, Reto Auer, Michael P. Bancks, David C. Goff, Cora E. Lewis, Mark J. Pletcher, Jamal S. Rana, James M. Shikany, Stephen Sidney, Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, American Journal of Public Health, 10.2105/AJPH.2017.303654, 107, 4, (601-606), (2017).
- Emma Childs, Joseph A. Lutz, Harriet de Wit, Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2017.03.030, 177, (136-144), (2017).
- S. Menahem, Cardiovascular Effects of Cannabis Usage, Handbook of Cannabis and Related Pathologies, 10.1016/B978-0-12-800756-3.00058-2, (481-485), (2017).
- Wayne Hall, Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes, International Journal of Drug Policy, 10.1016/j.drugpo.2016.10.021, 42, (57-62), (2017).
- Sherrie Khadanga, Philip A. Ades, What do we tell patients with coronary artery disease about marijuana use?, Coronary Artery Disease, 10.1097/MCA.0000000000000567, (1), (2017).
- John R. Richards, Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?, Medical Hypotheses, 10.1016/j.mehy.2017.04.018, 103, (90-95), (2017).
- Charles D. Ciccone, Medical Marijuana: Just the Beginning of a Long, Strange Trip?, Physical Therapy, 10.2522/ptj.20160367, 97, 2, (239-248), (2016).
- Geke AH van den Elsen, Lieke Tobben, Amir IA Ahmed, Robbert Jan Verkes, Cornelis Kramers, Radboud M Marijnissen, Marcel GM Olde Rikkert, Marjolein A van der Marck, Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial, Journal of Psychopharmacology, 10.1177/0269881116665357, 31, 2, (184-191), (2016).
- Eman I. Draz, Mervat M. Oreby, Eman A. Elsheikh, Lamia A. Khedr, Salwa A. Atlam, Marijuana use in acute coronary syndromes, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990.2016.1240800, 43, 5, (576-582), (2016).
- Stefania I. Papatheodorou, Hannah Buettner, Mary B. Rice, Murray A. Mittleman, Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States, Chest, 10.1016/j.chest.2015.12.033, 149, 6, (1428-1435), (2016).
- Anne Claire Desbois, Patrice Cacoub, Cannabis-Associated Vasculitis, Systemic Vasculitides: Current Status and Perspectives, 10.1007/978-3-319-40136-2, (377-383), (2016).
- Manfred Hauben, Jeffrey K. Aronson, Robin E. Ferner, Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP), Drug Safety, 10.1007/s40264-016-0392-2, 39, 5, (421-432), (2016).
- Omayma Alshaarawy, Hosam A. Elbaz, Cannabis use and blood pressure levels, Journal of Hypertension, 10.1097/HJH.0000000000000990, 34, 8, (1507-1512), (2016).
- Juliana Tournebize, Valérie Gibaja, Emmanuel Puskarczyk, Batric Popovic, Jean-Pierre Kahn, Myocarditis associated with cannabis use in a 15-year-old boy: A rare case report, International Journal of Cardiology, 10.1016/j.ijcard.2015.10.161, 203, (243-244), (2016).
- Moustafa Elsheshtawy, Priatharsini Sriganesh, Vasudev Virparia, Falgun Patel, Ashok Khanna, Synthetic Marijuana Induced Acute Nonischemic Left Ventricular Dysfunction, Case Reports in Cardiology, 10.1155/2016/9625758, 2016, (1-4), (2016).
- Masakazu Saitoh, Marcelo Rodrigues dos Santos, Stephan von Haehling, Muscle wasting in heart failure, Wiener klinische Wochenschrift, 10.1007/s00508-016-1100-z, 128, S7, (455-465), (2016).
- Jonathan Neyer, Abhimanyu Uberoi, Michele Hamilton, Jon A. Kobashigawa, Marijuana and Listing for Heart Transplant, Circulation: Heart Failure, 10.1161/CIRCHEARTFAILURE.115.002851, 9, 7, (2016).
- Scott H. Kollins, Erin N. Schoenfelder, Joseph S. English, Alex Holdaway, Elizabeth Van Voorhees, Benjamin R. O’Brien, Rachel Dew, Allan K. Chrisman, An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults, Journal of Substance Abuse Treatment, 10.1016/j.jsat.2014.07.014, 48, 1, (96-103), (2015).
- Donald E. Greydanus, Gabriel Kaplan, Louis E. Baxter, Dilip R. Patel, Cynthia L. Feucht, Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?, Disease-a-Month, 10.1016/j.disamonth.2015.01.004, 61, 4, (118-175), (2015).
- Gulser Esen Besli, Mehmet Alper Ikiz, Sema Yildirim, Selcuk Saltik, Synthetic Cannabinoid Abuse in Adolescents: A Case Series, The Journal of Emergency Medicine, 10.1016/j.jemermed.2015.06.053, 49, 5, (644-650), (2015).
- Marco Matteo Ciccone, Annagrazia Cecere, Annapaola Zito, Fiorella Devito, Francesca Cortese, Michele Moncelli, Michele Gesualdo, Santa Carbonara, Gabriella Ricci, Giovanni Quistelli, Antonio Gnoni, Luisa Vonghia, Anna Maria Sardanelli, Pietro Scicchitan, Cannabinoids and Endothelial Dysfunction, Pharmacologia, 10.5567/pharmacologia.2015.114.119, 6, 4, (114-119), (2015).
- Seong-Jin Yu, David Reiner, Hui Shen, Kou-Jen Wu, Qing-Rong Liu, Yun Wang, Time-Dependent Protection of CB2 Receptor Agonist in Stroke, PLOS ONE, 10.1371/journal.pone.0132487, 10, 7, (e0132487), (2015).
- Emilie Jouanjus, Maryse Lapeyre‐Mestre, Joelle Micallef, Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders, Journal of the American Heart Association, 10.1161/JAHA.113.000638, 3, 2, (2014).
- Badr M. Ibrahim, Abdel A. Abdel-Rahman, Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review, Journal of Advanced Research, 10.1016/j.jare.2013.03.008, 5, 2, (137-145), (2014).
- Matteo Anselmino, Mario Matta, Fiorenzo Gaita, Drug abuse, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e3283641b3d, 15, 7, (525-531), (2014).
- Benno Hartung, Silke Kauferstein, Stefanie Ritz-Timme, Thomas Daldrup, Sudden unexpected death under acute influence of cannabis, Forensic Science International, 10.1016/j.forsciint.2014.02.001, 237, (e11-e13), (2014).
- Denise C. Vidot, Guillermo Prado, WayWay M. Hlaing, Kristopher L. Arheart, Sarah E. Messiah, Emerging Issues for our Nation's Health: The Intersection of Marijuana Use and Cardiometabolic Disease Risk, Journal of Addictive Diseases, 10.1080/10550887.2014.882718, 33, 1, (1-8), (2014).
- Jean Lud Cadet, Veronica Bisagno, Christopher Mark Milroy, Neuropathology of substance use disorders, Acta Neuropathologica, 10.1007/s00401-013-1221-7, 127, 1, (91-107), (2013).
- Lauren Frost, Elizabeth Mostofsky, Joshua I. Rosenbloom, Kenneth J. Mukamal, Murray A. Mittleman, Marijuana use and long-term mortality among survivors of acute myocardial infarction, American Heart Journal, 10.1016/j.ahj.2012.11.007, 165, 2, (170-175), (2013).
- Anne Claire Desbois, Patrice Cacoub, Cannabis-Associated Arterial Disease, Annals of Vascular Surgery, 10.1016/j.avsg.2013.01.002, 27, 7, (996-1005), (2013).
- Adam J. Gordon, James W. Conley, Joanne M. Gordon, Medical Consequences of Marijuana Use: A Review of Current Literature, Current Psychiatry Reports, 10.1007/s11920-013-0419-7, 15, 12, (2013).
- Thouraya Filali, Dhaker Lahidheb, Mehdi Gommidh, Badii Jdaida, Nadhem Hajlaoui, Wafa Fehri, Habib Haouala, Spontaneous multivessel coronary artery dissection associated with cannabis use, Journal of Cardiology Cases, 10.1016/j.jccase.2012.08.002, 7, 1, (e4-e7), (2013).
- Mikkel Arendt, Povl Munk-Jørgensen, Leo Sher, Signe Olrik Wallenstein Jensen, Mortality following treatment for cannabis use disorders: Predictors and causes, Journal of Substance Abuse Treatment, 10.1016/j.jsat.2012.09.007, 44, 4, (400-406), (2013).
- Edward M. Sellers, Kerri Schoedel, Cindy Bartlett, Myroslava Romach, Ethan B. Russo, Colin G. Stott, Stephen Wright, Linda White, Paul Duncombe, Chien‐Feng Chen, A Multiple‐Dose, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray, Clinical Pharmacology in Drug Development, 10.1002/cpdd.36, 2, 3, (285-294), (2013).
- Bhaskar Purushottam, Vincent M. Figueredo, Sudden Cardiac Death and Addictive Chemical Substances, Electrical Diseases of the Heart, 10.1007/978-1-4471-4978-1, (441-460), (2013).
- Laura L. Boles Ponto, Daniel S. O'Leary, Julie Koeppel, Robert I. Block, G. Leonard Watkins, John C. W. Richmond, Christine A. Ward, Dean A. Clermont, Beth A. Schmitt, Richard D. Hichwa, Effect of Acute Marijuana on Cardiovascular Function and Central Nervous System Pharmacokinetics of [15O]Water: Effect in Occasional and Chronic Users, The Journal of Clinical Pharmacology, 10.1177/0091270004265699, 44, 7, (751-766), (2013).
- Wilson Z. Ray, Khaled M. Krisht, Alex Schabel, Richard H. Schmidt, Subarachnoid Hemorrhage from a Thoracic Radicular Artery Pseudoaneurysm after Methamphetamine and Synthetic Cannabinoid Abuse: Case Report, Global Spine Journal, 10.1055/s-0032-1331463, 3, 2, (119-123), (2012).
- Birgit Kraft, Is There Any Clinically Relevant Cannabinoid-Induced Analgesia, Pharmacology, 10.1159/000337376, 89, 5-6, (237-246), (2012).
- MB Forrester, K Kleinschmidt, E Schwarz, A Young, Synthetic cannabinoid and marijuana exposures reported to poison centers, Human & Experimental Toxicology, 10.1177/0960327111421945, 31, 10, (1006-1011), (2012).
- E. Kras, W. Mrabet, J. Trouvé, Accident vasculaire cérébral et cannabis : un lien méconnuStroke and cannabis: a little-known link, Annales françaises de médecine d'urgence, 10.1007/s13341-012-0196-7, 2, 5, (350-353), (2012).
- Roland J. Lamarine, Marijuana: Modern Medical Chimaera, Journal of Drug Education, 10.2190/DE.42.1.a, 42, 1, (1-11), (2012).
- Badr Mostafa Ibrahim, Abdel A. Abdel-Rahman, Role of brainstem GABAergic signaling in central cannabinoid receptor evoked sympathoexcitation and pressor responses in conscious rats, Brain Research, 10.1016/j.brainres.2011.07.046, 1414, (1-9), (2011).
- Joshua Simmons, Laura Cookman, Christopher Kang, Carl Skinner, Three cases of “spice” exposure, Clinical Toxicology, 10.3109/15563650.2011.584316, 49, 5, (431-433), (2011).
- Simon Lal, Neeraj Prasad, Manijeh Ryan, Sabrena Tangri, Mark S. Silverberg, Allan Gordon, Hillary Steinhart, Cannabis use amongst patients with inflammatory bowel disease, European Journal of Gastroenterology & Hepatology, 10.1097/MEG.0b013e328349bb4c, 23, 10, (891-896), (2011).
- Nutrition, Pharmacology, and Psychology in Sports, DeLee and Drez's Orthopaedic Sports Medicine, 10.1016/B978-1-4160-3143-7.00008-7, (399-461), (2010).
- Olivier Cottencin, Laurent Karila, Marc Lambert, Catherine Arveiller, Amine Benyamina, Alain Boissonas, Michel Goudemand, Michel Reynaud, Cannabis Arteritis: Review of the Literature, Journal of Addiction Medicine, 10.1097/ADM.0b013e3181beb022, 4, 4, (191-196), (2010).
- L Zuurman, P CCM Passier, M L de Kam, H J Kleijn, A F Cohen, J MA van Gerven, Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers, Journal of Psychopharmacology, 10.1177/0269881109106913, 24, 11, (1689-1696), (2009).
- Albert Stuart Reece, Chronic toxicology of cannabis, Clinical Toxicology, 10.1080/15563650903074507, 47, 6, (517-524), (2009).
- Wayne Hall, Louisa Degenhardt, Adverse health effects of non-medical cannabis use, The Lancet, 10.1016/S0140-6736(09)61037-0, 374, 9698, (1383-1391), (2009).
- Wayne Hall, The adverse health effects of cannabis use: What are they, and what are their implications for policy?, International Journal of Drug Policy, 10.1016/j.drugpo.2009.02.013, 20, 6, (458-466), (2009).
- Jan A. Lindsay, Angela L. Stotts, Charles E. Green, David V. Herin, Joy M. Schmitz, Cocaine Dependence and Concurrent Marijuana Use: A Comparison of Clinical Characteristics, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990902933860, 35, 3, (193-198), (2009).
- Kristin M. Caspers, Rebecca Yucuis, Lowell M. McKirgan, Ruth Spinks, Stephan Arndt, Lifetime Substance Misuse and 5-Year Incidence Rates of Emergent Health Problems Among Middle-Aged Adults, Journal of Addictive Diseases, 10.1080/10550880903182796, 28, 4, (320-331), (2009).
- Birgit Kraft, H. G. Kress, Cannabinoids in pain and palliative care medicine – hope or dope?, memo - Magazine of European Medical Oncology, 10.1007/s12254-009-0148-0, 2, 3, (166-172), (2009).
- L Zuurman, PCCM Passier, ML de Kam, HJ Kleijn, AF Cohen, JMA van Gerven, Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers, Journal of Psychopharmacology, 10.1177/0269881108091551, 23, 6, (633-644), (2008).
- Kenneth J. Mukamal, Malcolm Maclure, James E. Muller, Murray A. Mittleman, An exploratory prospective study of marijuana use and mortality following acute myocardial infarction, American Heart Journal, 10.1016/j.ahj.2007.10.049, 155, 3, (465-470), (2008).
- Massimo Montisci, Gaetano Thiene, Santo Davide Ferrara, Cristina Basso, Cannabis and cocaine: a lethal cocktail triggering coronary sudden death, Cardiovascular Pathology, 10.1016/j.carpath.2007.05.005, 17, 5, (344-346), (2008).
- Fernando Caudevilla Gálligo, Antonio Cabrera Majada, Efectos psicológicos del cannabis, FMC - Formación Médica Continuada en Atención Primaria, 10.1016/S1134-2072(08)70812-0, 15, 5, (282-290), (2008).
- L. Zuurman, C. Roy, RC Schoemaker, A. Hazekamp, J. den Hartigh, JCME Bender, R. Verpoorte, JL Pinquier, AF Cohen, JMA van Gerven, Effect of intrapulmonary tetrahydrocannabinol administration in humans, Journal of Psychopharmacology, 10.1177/0269881108089581, 22, 7, (707-716), (2008).
- Hassan Z. Khiabani, Jørg Mørland, Jørgen G. Bramness, Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis, European Journal of Internal Medicine, 10.1016/j.ejim.2007.06.031, 19, 8, (608-612), (2008).
- Jennifer T. Sneider, Harrison G. Pope, Marisa M. Silveri, Norah S. Simpson, Staci A. Gruber, Deborah A. Yurgelun-Todd, Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers, European Neuropsychopharmacology, 10.1016/j.euroneuro.2008.04.016, 18, 8, (612-619), (2008).
- Joseph Y.S. Ting, Letter to the Editor: “Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult”, Clinical Toxicology, 10.1080/15563650601073587, 45, 4, (432-434), (2008).
- Jag H. Khalsa, Medical and Health Consequences of Marijuana, Marijuana and the Cannabinoids, 10.1007/978-1-59259-947-9, (237-252), (2007).
- Ross H. Lowe, Erin L. Karschner, Eugene W. Schwilke, Allan J. Barnes, Marilyn A. Huestis, Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry, Journal of Chromatography A, 10.1016/j.chroma.2007.06.069, 1163, 1-2, (318-327), (2007).
- Arash Aryana, Mark A. Williams, Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty?, International Journal of Cardiology, 10.1016/j.ijcard.2006.08.001, 118, 2, (141-144), (2007).
- Irene Kotsalou, Panagiotis Georgoulias, Ioannis Karydas, Stefanos Fourlis, Chrysa Sioka, Antonis Zoumboulidis, Nikolaos Demakopoulos, A Rare Case of Myocardial Infarction and Ischemia in a Cannabis-Addicted Patient, Clinical Nuclear Medicine, 10.1097/01.rlu.0000252218.04088.ff, 32, 2, (130-131), (2007).
- A.H. Taylor, C. Ang, S.C. Bell, J.C. Konje, The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy, Human Reproduction Update, 10.1093/humupd/dmm018, 13, 5, (501-513), (2007).
- Steven B. Karch, Postmortem Considerations, Marijuana and the Cannabinoids, 10.1007/978-1-59259-947-9, (295-301), (2007).
- Yelena A. Shmist, Igor Goncharov, Maor Eichler, Vladimir Shneyvays, Ahuva Isaac, Zvi Vogel, Asher Shainberg, Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production, Molecular and Cellular Biochemistry, 10.1007/s11010-006-2346-y, 283, 1-2, (75-83), (2006).
- George F. Koob, Michel Le Moal, Cannabinoids, Neurobiology of Addiction, 10.1016/B978-012419239-3/50044-8, (289-337), (2006).
- A. Robert Segarra, A. Torres Giménez, A. Tejero Pociello, C. Campo López, J. Pérez de los Cobos, Efectos esperados y adversos del consumo de cannabis en sujetos dependientes de los tetrahidrocannabinoides, Trastornos Adictivos, 10.1016/S1575-0973(06)75115-7, 8, 3, (148-154), (2006).
- Nicolas Rodondi, Mark James Pletcher, Kiang Liu, Stephen Benjamin Hulley, Stephen Sidney, Marijuana Use, Diet, Body Mass Index, and Cardiovascular Risk Factors (from the CARDIA Study), The American Journal of Cardiology, 10.1016/j.amjcard.2006.03.024, 98, 4, (478-484), (2006).
- Paul F Smith, The safety of cannabinoids for the treatment of multiple sclerosis, Expert Opinion on Drug Safety, 10.1517/14740338.4.3.443, 4, 3, (443-456), (2005).
